Mixed Results with Novel Agent in PSC (CME/CE)

(MedPage Today) -- NGM282 didn ' t reduce ALP, but had other benefits in primary sclerosing cholangitis

Source: MedPage Today Gastroenterology - April 16, 2018 Category: Gastroenterology Source Type: news